These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 15997019)

  • 1. Predictors of treatment acceptance and completion in anorexia nervosa: implications for future study designs.
    Halmi KA; Agras WS; Crow S; Mitchell J; Wilson GT; Bryson SW; Kraemer HC
    Arch Gen Psychiatry; 2005 Jul; 62(7):776-81. PubMed ID: 15997019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 1-year follow-up of a multi-center treatment trial of adults with anorexia nervosa.
    Yu J; Stewart Agras W; Halmi KA; Crow S; Mitchell J; Bryson SW
    Eat Weight Disord; 2011 Sep; 16(3):e177-81. PubMed ID: 22290033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine after weight restoration in anorexia nervosa: a randomized controlled trial.
    Walsh BT; Kaplan AS; Attia E; Olmsted M; Parides M; Carter JC; Pike KM; Devlin MJ; Woodside B; Roberto CA; Rockert W
    JAMA; 2006 Jun; 295(22):2605-12. PubMed ID: 16772623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Participant recruitment for an anorexia nervosa treatment study.
    McDermott C; Agras WS; Crow SJ; Halmi K; Mitchell JE; Bryson S
    Int J Eat Disord; 2004 Jan; 35(1):33-41. PubMed ID: 14705155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does fluoxetine augment the inpatient treatment of anorexia nervosa?
    Attia E; Haiman C; Walsh BT; Flater SR
    Am J Psychiatry; 1998 Apr; 155(4):548-51. PubMed ID: 9546003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence-based treatment of anorexia nervosa.
    Fairburn CG
    Int J Eat Disord; 2005; 37 Suppl():S26-30; discussion S41-2. PubMed ID: 15852315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential weight restoration on olanzapine versus fluoxetine in identical twins with anorexia nervosa.
    Duvvuri V; Cromley T; Klabunde M; Boutelle K; Kaye WH
    Int J Eat Disord; 2012 Mar; 45(2):294-7. PubMed ID: 21344468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Obsessive-compulsive disorder, trichotillomania, and anorexia nervosa: a case report.
    Pryor TL; Martin RL; Roach N
    Int J Eat Disord; 1995 Dec; 18(4):375-9. PubMed ID: 8580925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomised controlled multicentre trial of treatments for adolescent anorexia nervosa including assessment of cost-effectiveness and patient acceptability - the TOuCAN trial.
    Gowers SG; Clark AF; Roberts C; Byford S; Barrett B; Griffiths A; Edwards V; Bryan C; Smethurst N; Rowlands L; Roots P
    Health Technol Assess; 2010 Mar; 14(15):1-98. PubMed ID: 20334748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of fluoxetine in anorexia nervosa before and after weight restoration.
    Sebaaly JC; Cox S; Hughes CM; Kennedy ML; Garris SS
    Ann Pharmacother; 2013 Sep; 47(9):1201-5. PubMed ID: 24259736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individual psychological therapy in the outpatient treatment of adults with anorexia nervosa.
    Hay PJ; Claudino AM; Touyz S; Abd Elbaky G
    Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD003909. PubMed ID: 26212713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenges in conducting a multi-site randomized clinical trial comparing treatments for adolescent anorexia nervosa.
    Lock J; Brandt H; Woodside B; Agras S; Halmi WK; Johnson C; Kaye W; Wilfley D
    Int J Eat Disord; 2012 Mar; 45(2):202-13. PubMed ID: 21495052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa.
    Kaye WH; Nagata T; Weltzin TE; Hsu LK; Sokol MS; McConaha C; Plotnicov KH; Weise J; Deep D
    Biol Psychiatry; 2001 Apr; 49(7):644-52. PubMed ID: 11297722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa.
    Barbarich NC; McConaha CW; Halmi KA; Gendall K; Sunday SR; Gaskill J; La Via M; Frank GK; Brooks S; Plotnicov KH; Kaye WH
    Int J Eat Disord; 2004 Jan; 35(1):10-5. PubMed ID: 14705152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open trial of fluoxetine in patients with anorexia nervosa.
    Kaye WH; Weltzin TE; Hsu LK; Bulik CM
    J Clin Psychiatry; 1991 Nov; 52(11):464-71. PubMed ID: 1744064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Olanzapine treatment of an adolescent girl with anorexia nervosa.
    Ercan ES; Copkunol H; Cýkoethlu S; Varan A
    Hum Psychopharmacol; 2003 Jul; 18(5):401-3. PubMed ID: 12858329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decision-making functioning as a predictor of treatment outcome in anorexia nervosa.
    Cavedini P; Zorzi C; Bassi T; Gorini A; Baraldi C; Ubbiali A; Bellodi L
    Psychiatry Res; 2006 Dec; 145(2-3):179-87. PubMed ID: 17074398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of dropout from inpatient treatment for anorexia nervosa.
    Roux H; Ali A; Lambert S; Radon L; Huas C; Curt F; Berthoz S; Godart N;
    BMC Psychiatry; 2016 Sep; 16(1):339. PubMed ID: 27716113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Termination of inpatient treatment for anorexia nervosa].
    Zeeck A; Herzog T
    Nervenarzt; 2000 Jul; 71(7):565-72. PubMed ID: 10989811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.